SHPH: 91% | Shuttle Pharmaceuticals shares are trading higher after the company announced it finalized agreements with all six of the planned site enrollment locations to administer the Phase 2 clinical trial of Ropidoxuridine.

VFC: 23% | VF shares are trading higher after the company reported better-than-expected Q2 financial results.

CROX: -12% | Crocs shares are trading lower after the company reported Q3 financial results and lowered its revenue guidance related to the HEYDUDE Brand.